Henry Maia Peixoto

Dr. Henry Maia Peixoto

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2014 in Memórias do Instituto Oswaldo Cruz
Verified
Journal Article
Open access
PDF file
Wuelton MonteiroWuelton Monteiro
Wuelton Monteiro
FVFernando Fa Val
Fernando Fa Val
ASAndré M Siqueira
André M Siqueira
GFGabriel P Franca
Gabriel P Franca
VSVANDERSON SOUZA SAMPAIO
VANDERSON SOUZA SAMPAIO
LGLacerda Marcus Vinícius G
Lacerda Marcus Vinícius G
Plasmodium vivax radical cure requires the use of primaquine (PQ), a drug that induces haemolysis in glucose-6-phosphate dehydrogenase deficient (G6PDd) individuals, which further hampers malaria control efforts. The aim of this work was to study the G6PDd prevalence and variants in Latin America (LA) and the Caribbean region. A systematic search of the published literature was undertaken in August 2013. Bibliographies of manuscripts were also searched and additional references were identified. Low prevalence rates of G6PDd were documented in Argentina, Bolivia, Mexico, Peru and Uruguay, but studies from Curaçao, Ecuador, Jamaica, Saint Lucia, Suriname and Trinidad, as well as some surveys carried out in areas of Brazil, Colombia and Cuba, have shown a high prevalence (> 10%) of G6PDd. The G6PD A-202A mutation was the variant most broadly distributed across LA and was identified in 81.1% of the deficient individuals surveyed. G6PDd is a frequent phenomenon in LA, although certain Amerindian populations may not be affected, suggesting that PQ could be safely used in these specific populations. Population-wide use of PQ as part of malaria elimination strategies in LA cannot be supported unless a rapid, accurate and field-deployable G6PDd diagnostic test is made available.

27 February 2019 in Transactions of the Royal Society of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
SMSamara Freire Valente Magalhães
Samara Freire Valente Magalhães
HPHenry Maia Peixoto
Henry Maia Peixoto
NMNoely Moura
Noely Moura
Wuelton MonteiroWuelton Monteiro
Wuelton Monteiro
MOMaria Regina Fernandes de Oliveira
Maria Regina Fernandes de Oliveira
Snakebite envenomation in the Brazilian Amazon is a recognized public health problem that does not receive the appropriate attention from key stakeholders. The morbidity rate is relevant, but still underestimated. Thus, the present study updates the current state of knowledge on snakebite envenomation in the Brazilian Amazon. It follows a descriptive method and contributes new knowledge about the dynamics of snakebites and the associated morbidity and mortality reported in the Brazilian Amazon. The study is based on information from cases registered and retrieved from the Brazilian Information System for Notifiable Diseases (Sistema de Informação de Agravos de Notificação-SINAN). The registers we studied covers a period of six years, 2010-2015. Most snakebites occurred in the states of Pará (30 693 cases, 43.34%) and Amazonas (9386 cases, 13.25%), with a higher prevalence in males of an economically active age. The main genus involved in bites was Bothrops sp. The mortality rate was 0.24 per hundred thousand and the case fatality rate was 0.51%. Although low case fatality and mortality rates were observed, much can still be done to prevent snakebites as they continue to be a serious public health problem considering the severity and potentially high economic impact for the individual and to society.

16 November 2018 in Tropical Medicine & International Health
Verified
Journal Article
Open access
PDF file
VWVirginia Kagure Wachira
Virginia Kagure Wachira
HPHenry Maia Peixoto
Henry Maia Peixoto
MOMaria Regina Fernandes de Oliveira
Maria Regina Fernandes de Oliveira
Objective: The objective of this study was to describe the factors associated with the development of Guillain–Barré syndrome, both infectious and non‐infectious, during and after the A(H1N1) influenza pandemic in 2009 and the recent Zika virus epidemic in the Americas.Method: Systematic review of literature on factors associated with the development of the Guillain–Barré syndrome published between 2007 and 2017 listed in EBSCO, MEDLINE and LILACS databases. The quality of the studies was evaluated using the Newcastle Ottawa Scale.Results: Thirty‐four articles met inclusion criteria and were selected for analysis. Their quality was considered good in relation to most of the items evaluated. Many aetiological agents had the results of association with Guillain–Barré syndrome, among them Campylobacter jejuni, influenza vaccine – both pandemic and seasonal vaccines, respiratory infection, gastrointestinal infection among others. The aetiological agents found are, in most part, the same reported prior to the study period. The association with surgeries, chikungunya virus (CHIKV), Zika virus and quadrivalent human papillomavirus vaccine stand out as new aetiological agents in the list of the various possible agents that trigger Guillain–Barré syndrome reported in the study period. There were no Brazilian studies identified during this period.Conclusions: The results of the review reaffirmed C. jejuni as the major trigger of GBS, whereas the association of influenza vaccines and GBS is less clear; Zika virus infection in association with GBS was found in only one study.

7 December 2014 in Tropical Medicine & International Health
Verified
Journal Article
Closed access
PDF file
HPHenry Maia Peixoto
Henry Maia Peixoto
MOMaria Regina Fernandes de Oliveira
Maria Regina Fernandes de Oliveira
GRGustavo Adolfo Sierra Romero
Gustavo Adolfo Sierra Romero

25 February 2014 in Malaria Journal
Verified
Journal Article
Open access
PDF file
Wuelton MonteiroWuelton Monteiro
Wuelton Monteiro
GFGabriel P Franca
Gabriel P Franca
GMGISELY DE MELO
GISELY DE MELO
AQAmanda Lm Queiroz
Amanda Lm Queiroz
MBMarcelo Brito
Marcelo Brito
MLMarcus Vinícius Guimarães de Lacerda
Marcus Vinícius Guimarães de Lacerda
Although G6PDd individuals are generally asymptomatic throughout their life, the clinical burden of this genetic condition includes a range of haematological conditions, including acute haemolytic anaemia (AHA), neonatal jaundice (NNJ) and chronic non-sphaerocytic anaemia (CNSA). In Latin America (LA), the huge knowledge gap regarding G6PDd is related to the scarce understanding of the burden of clinical manifestation underlying G6PDd carriage. The aim of this work was to study the clinical significance of G6PDd in LA and the Caribbean region through a systematic review.

1 August 2016 in Revista da Sociedade Brasileira de Medicina Tropical
Verified
Journal Article
Open access
PDF file
MBMarcelo Augusto Mota Brito
Marcelo Augusto Mota Brito
HPHenry Maia Peixoto
Henry Maia Peixoto
AAAnne Cristine Gomes de Almeida
Anne Cristine Gomes de Almeida
MOMaria Regina Fernandes de Oliveira
Maria Regina Fernandes de Oliveira
GRGustavo Adolfo Sierra Romero
Gustavo Adolfo Sierra Romero
MLMarcus Vinícius Guimarães de Lacerda
Marcus Vinícius Guimarães de Lacerda
Keywords: Malaria; Plasmodium vivax; Glucose-6-phosphate dehydrogenase deficiency; Care Start G6PD